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1. Introduction 
Acetylcholinesterase can be fractionated, by 
differential sedimentation in density gradients, into 
several stable molecular forms [1]. These molecules 
do not appear to differ in their catalytic activity per 
active site [2],but correspond to different quaternary 
associations [3]: in addition to a variable number of 
active subunits ome acetylcholinesterase molecules 
obtained from Electrophorus and Torpedo electric 
organs have been shown to contain a structural rod- 
like element, or tail [4,5], collagen-like in nature 
[6,7], which is thought o be involved in the immo- 
bilisation of the enzyme within the synaptic left 
[8-101. 
Analyses of mammalian acetylcholinesterase have 
thus far been mostly performed on enzymes from rat 
tissues [11-14]. Recent experiments performed 
mainly with bovine superior cervical ganglion enzymes, 
led us to the conclusion that the various forms of 
mammalian acetylcholinesterase re structurally 
similar to those of electric organs [15]. There are three 
globular forms, which are monomers (G1,4 S), dimers 
(G2, 6 S) and tetramers (G4, 10 S) of the catalytic 
subunits, and three asymmetric tailed form, con- 
taining one, two or three tetramers (A4, 9 S; As, 
13 S; AlZ, 16 S). These asymmetric molecules 
reversibly precipitate in low salt conditions, a
Abbreviations: EC 31.1.7 acetylcholinesterase, molecular 
forms G1, G2, G4, A4, A 8, Al2; the letter indicates the 
globular or asymmetric nature of the molecule and the 
subscript i s number of catalytic subunits 
property which appears to involve the same type of 
interactions as the aggregation of the electric organ 
enzymes. 
The heaviest molecule, A12, which is the pre- 
dominant asymmetric form, has attracted much 
attention since its location exclusively in the endplate- 
containing region of the rat diaphragm was shown [I 1 ]. 
This result was confirmed and extended to other rat 
muscles [13]. After two weeks of denervation this 
form disappears from the endplate, and reappears at 
the site of neuromuscular contact when the muscle is 
reinnervated, either at the original endplate site, or 
an ectopic site [ 11,13]. In primary cultures of muscle 
cells from young rat embryos, the heavy asymmetric 
form can be induced by the presence of spinal chord 
explants [16]. 
The presence of the 16 S form has therefore been 
considered a biochemical marker for nerve-muscle 
interactions. If this were the case for human muscle, 
analysis of acetylcholinesterase might provide a con- 
venient and precise tool for the recognition of potential 
abnormalities such as occur in various neuromuscular 
diseases. 
We report here an investigation ofacetylcholinesterase 
in normal human muscle in which we compared 
endplate-containing and endplate-less amples obtained 
from biopsies of intercostal muscle, removed uring 
surgical operations performed on patients with no 
neuromuscular bnormalities. A parallel series of 
experiments performed on biopsies from the deltoid, 
peroneus or gastrocnemius muscles from patients 
suffering from various neuromuscular disorders 
yielded similar results. 
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2. Materials and methods 
Small bundles of fibers were prepared from the 
biopsy specimen, about 8-10 mm long from tendon 
to tendon, and 0.5 mm wide. These were teased 
under the stereomicroscope in order to observe the 
nerve in the medial part of the bundle. The bundle 
was then separated into two sections, one containing 
the neural zone (neuromuscular junctions), as well as 
an aneural segment, and the other containing no end- 
plates. Some fibers were detached from each of 
these sections and stained by Koelle's method to 
determine the presence of endplates [ 17]. The rest of 
the sections were stored in liquid nitrogen for bio- 
chemical analysis. (No difference in sedimentation 
profiles for a given individual was seen in biopsies 
used immediately or after storage in liquid nitrogen 
for up to 2 months.) The fractions (5-20 mg) were 
finally minced with a razor blade and homogenised 
with 20 vol. Triton X-100 saline buffer (1 M NaC1, 
50 mM MgC12, 10 mM Tris-HC1, pH 7, 1% Triton 
X-100) in a Teflon-glass Potter homogenizer. The 
extracts were analysed immediately after 
homogeneisation: 200 #1 aliquots were layered on 
5-20% sucrose gradients (in the same medium) and 
centrifuged for 21 h at 38 000 rev./min, in a SW 41 
Beckman rotor, at 4°C. The following enzymes were 
included as sedimentation coefficient standard: 
E. coli/3-galactosidase (16 S), beef liver catalase 
(11.3 S) and alcohol dehydrogenase from yeast 
A 
I I 10 20 30 I I 40 
(7.4 S). Aliquots of the fractions were assayed with 
the Ellman method as in [12], in the presence of 
10/aM ethopropazine (100/A in 1 ml medium for 
~3 h). 
3. Results 
3.1. Molecular forms of human acetylcholinesterase 
Human muscle was found to contain both specific 
acetylcholinesterase ndnon-specific cholinesterase. 
The 'non-specific' omponent amounted to ~5% of 
the total cholinesterasic a tivity. This is markedly 
less than in rat muscle, where the proportion is 15% 
[18]. In our analyses, we specifically inhibited the 
'non-specific' holinesterase, and analysed only the 
molecular forms of the specific acetylcholinesterase, 
by zone sedimentation in sucrose gradients. Six 
molecular forms could be identified (fig.1,2) and 
appeared exactly homologous to those which have 
been previously characterized in other mammals 
such as rat and ox. The sedimentation coefficients 
are essentially identical for the corresponding forms 
and as reported [15] in the case ofox, rat and 
chicken, three of these molecules remain soluble in 
low salt (globular or G forms) whereas three others 
reversibly precipitate under such conditions (asym- 
metric or A forms) (table 1). 
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Fig.1. Sedimentation patterns of human acetylcholinesterase. (A) Unfractionated saline extract (1 M NaC1, 0.05 M MgC12, 0.01 M 
Tris-HCl, pH 7, 1% Triton X-100). (B) Low salt soluble (m . . . .  m) and insoluble components (o o). The low salt (0.04 M 
MgCI~, 0.01 M Tris-HCl, pH 7, 1% Triton X-100) precipitate was redissolved in saline buffer and both components were cen- 
trifuged in the same medium. The sucrose gradient (5.2% w/v) were centrifuged as indicated in section 2. Activities are plotted 
with an arbitrary scale as a function of fraction number. The A variation was < 1 unit, i.e., in the linear range. 
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Table 1 
Sedimentation coefficient of the acetylcholinesterase 
molecular forms in human muscle 
Globular forms Asymmetric forms 
G1 G2 G4 A4 A8 A12 
3.5 S 6 S 11 S 9.5 S 13.3 S 16.7 S 
The sedimentation coefficients indicated correspond to the 
apparent values, obtained under our experimental conditions 
In spite of the clear homology between individual 
forms of acetylcholinesterase, th ir relative proportions 
differ markedly in human and rat muscles (see fig.2): 
(i) The proportion of the G2 form in human muscle 
is much larger than that in rat muscle where it 
represented only a minor portion of the total 
acetylcholinesterase ctivity; 
(ii) The proportion of the A8 (13 S) component is
markedly larger than in rat, where its existence 
has been recognized only recently [15 ]; 
(iii) The slower sedimenting asymmetric component 
(A4) is readily detectable while it is not in the 
rat, where it is masked by the G4 component 
which is far more abundant (> 30%) than in 
human extracts (< 10%). 
In addition to global species-specific differences, 
the profiles shown in fig.2 illustrate a very large 
variability among human individuals. For instance, 
the heavy A12 form was found to vary from < 10% 
to nearly 30% of the total activity. There was no 
obvious correlation between acetylcholinesterase 
profiles and variables uch as age, sex or health 
condition. These individual differences might be of 
genetic origin, but this hypothesis should be sub- 
stantiated by further studies. It is interesting that no 
such variations have been observed among laboratory 
rats, but studies with animals of different genetic 
background have not yet been undertaken. 
Fig.2. Sedimentation patterns of rat and human muscle 
acetylcholinesterase (intercostal muscle xtracts). (A) Rat 
muscle acetylcholinesterase; (B,C) human muscle acetyl- 
cholinesterase from two different individuals. The specific 
activities of the homogenates were 0.35 nmol/h/mg protein 
in the case of rat intercostal muscle and varied from 
0.35-0.6 in the case of human muscle samples. 
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3.2. Distribution of molecular fomzs in hmervated and 
non-innervated sections 
As shown in fig.3, we characterised sections from 
normal intercostal biopsies from 6 patients with and 
without endplates and we analysed their acetyl- 
cholinesterase molecular forms. In all sections from a 
given individual, we obtained identical patterns in 
innervated and non-innervated sections. 
The same conclusion was reached when we 
examined the patterns of endplate-less and endplate- 
containing sections in 17 9athological cases. There 
was no correlation therefore between the presence of 
endplates and the occurrence of any particular molec- 
ular form. In particular, the A12 (16 S) form was 
present in all sections with the same relative activity. 
It is thus clear that this form, which was sometimes 
called 'endplate form' according to the observations 
F , : : :  
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Fig.3. Neural and aneural sections of muscle. (A) Endplates 
are clearly visible in 1 and absent in II. (B) Acetylcholinesterase 
sedimentation profiles of the muscle shown in (A). The two 
proFdes correspond to neural (e - -e )  and aneural (o - - -o )  
regions of the muscle; the variation between the 2 profiles is 
the same as for two profiles of similar egions and ~eflect the 
dispersion of experimental results. 
made on various rat muscles [11,13] is not restricted 
to endplates in human skeletal muscle. 
4. Discussion 
It is very likely that the aggregating properties 
which are characteristic of the collagen-tailed 
asymmetric molecules of acetylcholinesterase, allow 
the binding of this enzyme to polyanionic omponents 
of the basal amina. Such interactions might in 
particular account for its functional localisation 
within the synaptic left. Such a mechanism appeared 
remarkably consistent with the endplate localisation 
of the asymmetric molecules, as observed in rat 
muscles [ 11,13]. It is therefore surprising that no such 
preferential localisation existed in human muscle. 
Another similar situation has however been 
reported [16] where muscles cells from day 18 rat 
embryos were observed to synthetize A12 acetyl- 
cholinesterase in absence of neural elements (in 
contrast with cells from day 13 embryos) and that 
no patches of esteratic activity appeared on the 
surface of these cells. It remains however quite 
possible that the synthesis of the A forms of acetyl- 
cholinesterase by muscle cells requires to be triggered 
by neural induction. Such a regulation might represent 
a phenomenon quite distinct from an endplate- 
restricted localisation. 
The description [19] of a myasthenic syndrome in 
which endplate potentials were abnormally long and 
unresponsive to anticholinesterasic drugs and in 
which the Aa2 form was missing, was considered in 
[19] as evidence that this form is indeed subject o a 
well-defined regulation and might even be the only 
physiologically active form of acetylcholinesterase in 
human muscle. We observed, however, very low 
levels of this molecule and more generally of all 
asymmetric molecules, in some apparently quite 
normal individuals. 
The two main conclusions of this study are that 
in mammalian muscles the heavy asymmetric forms 
are not necessarily ocalised at the endplate and that 
their levels are not simply correlated with physiological 
conditions. A more precise comprehension f the 
role of the various molecular forms will deserve 
further study. 
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